Literature DB >> 24240117

Exercise training in polycystic ovarian syndrome enhances flow-mediated dilation in the absence of changes in fatness.

Victoria S Sprung1, Daniel J Cuthbertson, Christopher J A Pugh, Nabil Aziz, Graham J Kemp, Christina Daousi, Daniel J Green, Nigel Timothy Cable, Helen Jones.   

Abstract

INTRODUCTION: Polycystic ovarian syndrome (PCOS) is associated with an adverse cardiovascular disease (CVD) profile. A surrogate marker for CVD risk is endothelial dysfunction. Limited studies exist examining the cardiovascular and metabolic effects of exercise in PCOS and specifically its impact on endothelial function. Therefore, the aim of the current study was to investigate the impact of exercise on endothelial function, in parallel with body composition, insulin resistance, and cardiopulmonary fitness in PCOS.
METHODS: Ten women with PCOS (27 yr, 95% confidence interval [CI] = 23-32; 31 kg·m⁻², 95% CI = 28-34) completed a 16-wk exercise (EX) program, and seven women with PCOS (29 yr, 95% CI = 24-35; 35 kg·m⁻², 95% CI = 31-40) undertook conventional care (CC) following lifestyle advice. Brachial artery endothelial function was assessed pre- and postintervention using flow-mediated dilation adjusted for variability in baseline diameter. Visceral and abdominal subcutaneous adipose tissue was assessed using whole-body magnetic resonance imaging and ¹H magnetic resonance spectroscopy quantified liver fat. Cardiorespiratory fitness, glycemic control, hormone, and lipid profiles were also assessed. Data were analyzed using covariate-controlled generalized estimating equations.
RESULTS: At follow-up, EX improved flow-mediated dilation by 3.6% (95% CI = 0.5-6.7, P = 0.03) more than CC. There was a parallel improvement in cardiorespiratory fitness of 4.7 mL·kg⁻¹·min⁻¹ (95% CI = 1.4-7.9, P < 0.001) with EX versus CC. These changes were not explained by changes in visceral adipose tissue, subcutaneous adipose tissue, liver fat or insulin resistance.
CONCLUSIONS: Supervised exercise in women with PCOS improves endothelial function, an adaptation associated with reduced CVD risk. This change occurs independent of changes in body weight or composition. The success of public health interventions in this patient group should not be solely judged by weight loss.

Entities:  

Mesh:

Year:  2013        PMID: 24240117     DOI: 10.1249/MSS.0b013e31829ba9a1

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  13 in total

1.  Heat therapy improves glucose tolerance and adipose tissue insulin signaling in polycystic ovary syndrome.

Authors:  Brett R Ely; Zachary S Clayton; Carrie E McCurdy; Joshua Pfeiffer; Karen Wiedenfeld Needham; Lindan N Comrada; Christopher T Minson
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-05-28       Impact factor: 4.310

2.  Exercise Recommendations for Women with Polycystic Ovary Syndrome: Is the Evidence Enough?

Authors:  Nigel K Stepto; Rhiannon K Patten; Eliza C Tassone; Marie L Misso; Leah Brennan; Jacqueline Boyle; Russell A Boyle; Cheryce L Harrison; Angelica Lindén Hirschberg; Kate Marsh; Alba Moreno-Asso; Leanne Redman; Mala Thondan; Chandrika Wijeyaratne; Helena J Teede; Lisa J Moran
Journal:  Sports Med       Date:  2019-08       Impact factor: 11.136

Review 3.  Is cardiorespiratory fitness impaired in PCOS women? A review of the literature.

Authors:  S Donà; E Bacchi; P Moghetti
Journal:  J Endocrinol Invest       Date:  2016-12-27       Impact factor: 4.256

4.  Lifestyle changes in women with polycystic ovary syndrome.

Authors:  Siew S Lim; Samantha K Hutchison; Emer Van Ryswyk; Robert J Norman; Helena J Teede; Lisa J Moran
Journal:  Cochrane Database Syst Rev       Date:  2019-03-28

Review 5.  Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.

Authors:  Krystallenia I Alexandraki; Eleni A Kandaraki; Kalliopi-Anna Poulia; Christina Piperi; Eirini Papadimitriou; Theodoros G Papaioannou
Journal:  touchREV Endocrinol       Date:  2021-04-28

Review 6.  Cardiometabolic risk in polycystic ovary syndrome.

Authors:  Katica Bajuk Studen; Marija Pfeifer
Journal:  Endocr Connect       Date:  2018-05-29       Impact factor: 3.335

7.  Exercise-induced improvements in liver fat and endothelial function are not sustained 12 months following cessation of exercise supervision in nonalcoholic fatty liver disease.

Authors:  C J A Pugh; V S Sprung; H Jones; P Richardson; F Shojaee-Moradie; A M Umpleby; D J Green; N T Cable; M I Trenell; G J Kemp; D J Cuthbertson
Journal:  Int J Obes (Lond)       Date:  2016-07-21       Impact factor: 5.095

8.  Effects of High Intensity Interval Training and Strength Training on Metabolic, Cardiovascular and Hormonal Outcomes in Women with Polycystic Ovary Syndrome: A Pilot Study.

Authors:  Ida Almenning; Astrid Rieber-Mohn; Kari Margrethe Lundgren; Tone Shetelig Løvvik; Kirsti Krohn Garnæs; Trine Moholdt
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

9.  Exercise Interventions in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Rhiannon K Patten; Russell A Boyle; Trine Moholdt; Ida Kiel; William G Hopkins; Cheryce L Harrison; Nigel K Stepto
Journal:  Front Physiol       Date:  2020-07-07       Impact factor: 4.566

Review 10.  Sex differences in vascular aging in response to testosterone.

Authors:  Kerrie L Moreau; Matthew C Babcock; Kerry L Hildreth
Journal:  Biol Sex Differ       Date:  2020-04-15       Impact factor: 5.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.